Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR

Gavi, the Vaccine Alliance, in collaboration with partners, is announcing support for human rabies vaccines for post exposure prophylaxis (PEP) as part of routine immunisation. Eligible countries are receiving guidance on how to access these vaccines under Gavi’s cofinancing policy. The first round of applications will be reviewed in July 2024. Ninety-five percent of human rabies deaths occur in Africa and Asia, most often in marginalised communities that lack access to care.

Continue reading...